Executive record

Tomas Cihlar, Ph.D.

Director at ASSEMBLY BIOSCIENCES, INC.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:tomas-cihlar-ph-dVersion: public-0As of: 2026-09-30

Not yet claimed11 published Claims4 sources
  • Director

Key Claims

Biography

Dr. Cihlar has served in positions of increasing responsibility with Gilead since 1994, most recently as Senior Vice President, Virology since October 2021. He has extensive experience in infectious disease field, leadership of antiviral discovery programs, and oversight of research programs in HIV, hepatitis, herpes, respiratory and emerging viral infections. He was designated to serve on the Board pursuant to the Investors Rights Agreement with Gilead.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. 2026 to end not publishedExecutive title: Director · Organization not publishedASMB DEF 14A executive officers
  2. Dates not publishedExecutive title: Senior Vice President, Virology · Organization not publishedASMB DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ASMB DEF 14A director slate

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 15, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Gilead Sciences, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Senior Vice President, Virology · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. ASMB DEF 14A executive officers

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at ASSEMBLY BIOSCIENCES, INC. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Director · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  3. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at ASSEMBLY BIOSCIENCES, INC. · Claim reviewed: May 15, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of ASSEMBLY BIOSCIENCES, INC. · Claim reviewed: May 15, 2026